A Primer on Foreign Corrupt Practices Act and Anti-Corruption Issues for Healthcare and Life Science Companies, Part III: Defensive Strategies in Conducting an FCPA Compliance Investigation and Responding to a Government Inquiry 

Thursday, July 14, 2011 This webinar series is brought to you by the Fraud and Abuse Practice Group, and is co-sponsored by the Healthcare Liability and Litigation, Hospitals and Health Systems, Life Sciences, and Teaching Hospitals and Academic Medical Centers Practice Groups.

Description

Part III of this series will focus on the following topics:

• Strategies for making the preliminary assessment of a potential anti-corruption issue
• When to get outside help
• Best practices in conducting interviews with current employees
• Protecting the attorney-client and work product privileges
• How European privacy laws impact the company’s records and requests for information
• To disclose or not to disclose the company’s findings to U.S. or foreign authorities
• Responding to U.S. and/or foreign government investigations

Learn more about Part I or Part II.

Presenters

• John "Jay" S. Darden, Esquire
  Partner
  Patton Boggs LLP, Washington, DC
  
  
• John E. Kelly, Esquire
  Partner
  Fulbright & Jaworski LLP, Washington, DC

Moderator

• Carol A. Poindexter, Esquire
  Partner
  Shook Hardy & Bacon LLP, Washington, DC, and Kansas City, MO